Search by Drug Name or NDC

    NDC 54092-0476-08 Lialda 1.2 g/1 Details

    Lialda 1.2 g/1

    Lialda is a ORAL TABLET, DELAYED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Takeda Pharmaceuticals America, Inc.. The primary component is MESALAMINE.

    Product Information

    NDC 54092-0476
    Product ID 54092-476_466df3d0-83f7-4082-b08a-1674b8e6a9e5
    Associated GPIs 52500030000670
    GCN Sequence Number 062058
    GCN Sequence Number Description mesalamine TABLET DR 1.2 G ORAL
    HIC3 D6F
    HIC3 Description DRUG TX-CHRONIC INFLAM. COLON DX,5-AMINOSALICYLAT
    GCN 97842
    HICL Sequence Number 001848
    HICL Sequence Number Description MESALAMINE
    Brand/Generic Brand
    Proprietary Name Lialda
    Proprietary Name Suffix n/a
    Non-Proprietary Name mesalamine
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, DELAYED RELEASE
    Route ORAL
    Active Ingredient Strength 1.2
    Active Ingredient Units g/1
    Substance Name MESALAMINE
    Labeler Name Takeda Pharmaceuticals America, Inc.
    Pharmaceutical Class Aminosalicylate [EPC], Aminosalicylic Acids [CS]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA022000
    Listing Certified Through 2024-12-31

    Package

    NDC 54092-0476-08 (54092047608)

    NDC Package Code 54092-476-08
    Billing NDC 54092047608
    Package 3 CARTON in 1 CARTON (54092-476-08) / 8 BLISTER PACK in 1 CARTON / 1 TABLET, DELAYED RELEASE in 1 BLISTER PACK
    Marketing Start Date 2007-01-16
    NDC Exclude Flag N
    Pricing Information N/A